NCT02213835

Brief Summary

The aim of this study is to determine the tolerability and potential efficacy of dietary therapy, the Specific Carbohydrate Diet (SCD), in pediatric patients with Crohn's disease (CD) and Ulcerative Colitis (UC). This is a single center, open labelled study designed to determine tolerability, preliminary safety and potential efficacy in pediatric patients with CD and UC. The study patients will be recruited from Seattle Children's GI clinic. the investigators will enroll 10 patients with mild to moderate CD (defined as PCDAI score of 10-29) or Ulcerative colitis (PUCAI 10-60) ages 8 to 21 years. Each patient will be in the study for approximately 12 weeks.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
9

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2014

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

August 4, 2014

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 12, 2014

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2017

Completed
Last Updated

May 24, 2019

Status Verified

May 1, 2018

Enrollment Period

3.3 years

First QC Date

August 4, 2014

Last Update Submit

May 22, 2019

Conditions

Keywords

Crohn's disease and Ulcerative colitis

Outcome Measures

Primary Outcomes (1)

  • Change in Pediatric Crohn's disease Activity Index/Pediatric Ulcerative Colitis Activity Index at baseline and 12 weeks

    Pediatric Crohn's disease Activity Index/Pediatric Ulcerative Colitis Activity Index are validated measures of disease activity for pediatric Crohn's disease and ulcerative colitis respectively.

    12 Week

Secondary Outcomes (1)

  • Change of common Laboratory measures including Complete Blood Count, sedimentation rate, C-Reactive Protein, stool Calprotectin at baseline and 12 weeks

    12 weeks

Other Outcomes (1)

  • Stool Microbiome Analysis from baseline and 12 weeks

    12 Weeks

Study Arms (1)

Specific Carbohydrate diet (SCD)

EXPERIMENTAL

The treatment for this study will be the Specific Carbohydrate diet (SCD). Intervention will be based upon standard dietary therapy as well as a nutritional handbook developed in the Gastroenterology division. Patients will receive one-on-one guidance by a Seattle Children's Dietician trained in the SCD during each visit. Prior to each visit patient will fill out a 3 day nutrition log which will be reviewed by the dietician during the clinic visit. Each patient will receive books on the SCD therapy which will include recipes and information about the diet The two books given will include "Breaking the Vicious Cycle" by Elaine Gottschall and "Recipes for the Specific Carbohydrate Diet" by Raman Prasad.

Other: Specific Carbohydrate diet (SCD)

Interventions

Specific Carbohydrate diet (SCD)

Eligibility Criteria

Age8 Years - 21 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Children and adolescents eight to twenty one years old
  • Diagnosis of Ulcerative colitis or Crohn's Disease made by a primary gastroenterologist based upon history, physical exam, laboratory/radiological studies and gastrointestinal histology
  • Mild or moderate disease activity based upon PCDAI score (10-45) or PUCAI score (10-60)
  • Parent/guardian and child must be able to comprehend the consent and assent
  • Parent/guardian and participant must be able to attend study visits at baseline, and weeks +2, +4, +8, +12.
  • Patient must not have medication changes for his/her inflammatory bowel disease medications for at least 1 months, unless medically necessary.

You may not qualify if:

  • Severe disease with PCDAI \>45 or PUCAI \>60
  • Active or history of intraabdominal abscess, intraabdominal fistula, stricturing Crohn's disease
  • Other serious medical conditions such as neurological, liver, kidney, autoimmune or systemic disease.
  • Has begun TNF inhibitors within two months prior to study
  • Has had change of maintenance medication within the last month
  • Tobacco, alcohol or illicit drug abuse
  • Pregnant subject recipients will be excluded

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seattle Children's Hospital

Seattle, Washington, 98105, United States

Location

Related Publications (2)

  • Suskind DL, Wahbeh G, Gregory N, Vendettuoli H, Christie D. Nutritional therapy in pediatric Crohn disease: the specific carbohydrate diet. J Pediatr Gastroenterol Nutr. 2014 Jan;58(1):87-91. doi: 10.1097/MPG.0000000000000103.

    PMID: 24048168BACKGROUND
  • Braly K, Williamson N, Shaffer ML, Lee D, Wahbeh G, Klein J, Giefer M, Suskind DL. Nutritional Adequacy of the Specific Carbohydrate Diet in Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2017 Nov;65(5):533-538. doi: 10.1097/MPG.0000000000001613.

MeSH Terms

Conditions

Crohn DiseaseColitis, Ulcerative

Condition Hierarchy (Ancestors)

Inflammatory Bowel DiseasesGastroenteritisGastrointestinal DiseasesDigestive System DiseasesIntestinal DiseasesColitisColonic Diseases

Study Officials

  • David L Suskind, MD

    Seattle Children's Hospital and The University of Washington

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor of Pediatrics

Study Record Dates

First Submitted

August 4, 2014

First Posted

August 12, 2014

Study Start

June 1, 2014

Primary Completion

September 1, 2017

Study Completion

September 1, 2017

Last Updated

May 24, 2019

Record last verified: 2018-05

Data Sharing

IPD Sharing
Will not share

Not discussed

Locations